YU40098A - Upotreba olanzapina za dobijanje leka - Google Patents

Upotreba olanzapina za dobijanje leka

Info

Publication number
YU40098A
YU40098A YU40098A YU40098A YU40098A YU 40098 A YU40098 A YU 40098A YU 40098 A YU40098 A YU 40098A YU 40098 A YU40098 A YU 40098A YU 40098 A YU40098 A YU 40098A
Authority
YU
Yugoslavia
Prior art keywords
olanzapine
preparation
medicine
insomnia
treatment
Prior art date
Application number
YU40098A
Other languages
English (en)
Inventor
Van Pierre Tran
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606731.9A external-priority patent/GB9606731D0/en
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of YU40098A publication Critical patent/YU40098A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Ovaj pronalazak opisuje upotrebu olanzapina za dobijanje leka korisnog kod lečenja nesanice.
YU40098A 1996-03-11 1998-09-11 Upotreba olanzapina za dobijanje leka YU40098A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1312696P 1996-03-11 1996-03-11
GBGB9606731.9A GB9606731D0 (en) 1996-03-29 1996-03-29 Method for treating insomnia

Publications (1)

Publication Number Publication Date
YU40098A true YU40098A (sh) 1999-09-27

Family

ID=26309028

Family Applications (1)

Application Number Title Priority Date Filing Date
YU40098A YU40098A (sh) 1996-03-11 1998-09-11 Upotreba olanzapina za dobijanje leka

Country Status (15)

Country Link
EP (1) EP0795330A1 (sh)
JP (1) JP2000506528A (sh)
KR (1) KR19990087712A (sh)
CN (1) CN1212627A (sh)
AU (1) AU724245B2 (sh)
BR (1) BR9708181A (sh)
CA (1) CA2248758A1 (sh)
CZ (1) CZ290198A3 (sh)
EA (1) EA000793B1 (sh)
IL (1) IL126160A0 (sh)
NO (1) NO984190L (sh)
NZ (1) NZ331846A (sh)
TR (1) TR199801800T2 (sh)
WO (1) WO1997033587A1 (sh)
YU (1) YU40098A (sh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA86265C2 (uk) * 2004-09-21 2009-04-10 Хипнион, Инк. Аналог локсапіну та його застосування для регулювання сну

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
CN1212627A (zh) 1999-03-31
EA199800818A1 (ru) 1999-02-25
TR199801800T2 (xx) 1998-12-21
KR19990087712A (ko) 1999-12-27
AU2198997A (en) 1997-10-01
IL126160A0 (en) 1999-05-09
AU724245B2 (en) 2000-09-14
CZ290198A3 (cs) 1999-09-15
NZ331846A (en) 2000-07-28
NO984190D0 (no) 1998-09-11
EA000793B1 (ru) 2000-04-24
JP2000506528A (ja) 2000-05-30
BR9708181A (pt) 1999-07-27
WO1997033587A1 (en) 1997-09-18
CA2248758A1 (en) 1997-09-18
EP0795330A1 (en) 1997-09-17
NO984190L (no) 1998-09-11

Similar Documents

Publication Publication Date Title
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
DK1036058T3 (da) Adamantanderivater
DK1036059T3 (da) Adamantanderivater
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
ITUD930123A0 (it) Scocca smontabile per poltrona da ufficio
BR9708528A (pt) Terapia com libertação uniforme de droga
DE59204364D1 (de) Zahnärztlicher Patientenstuhl.
NO911429L (no) Stoffbehandling.
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
ZA968990B (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases.
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
ITMI912509A1 (it) Uso della nimesulide nel trattamento della cataratta
ITMI910456A0 (it) Composizione farmaceutica per il trattamento della cataratta
FI973185A (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
NO911430D0 (no) Stoffbehandlingsmetode.
YU40098A (sh) Upotreba olanzapina za dobijanje leka
NO990949D0 (no) Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av AIDS
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
BR9708037A (pt) Método para o tratamento de abuso de substância
TR199501530A1 (tr) Osteoporoz tedavisinde terapötik döngüde kullanim icin kit.
ITRM930154A0 (it) Uso di terbinafina per il trattamento terapeutico della pneumocistosi.
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
IT9048026A0 (it) Preparato farmaceutico e/o cosmetico.
DK236489D0 (da) Anvendelse af diazepinoner til terapeutisk behandling af mikrokredsloebsforstyrrelser